Dermatology Snapshots

Does Senital Node Biopsy improve survival in melanoma patients?

Co-treating Ixekizumab With Tirzepatide - does it enhance response?

Adjuvant cemiplimab in high-risk SCC, does it help?

Do we need to do CXR before starting methotrexate?

How effective are systemics at controlling generalised pustular psoriasis?

Stage IIC vs IIIA melanoma survival analysis

Salt immersion as a treatment for warts

Targeted reapplication of treatment for scabies in infants

Changes to Advice and Guidance in NHS England

Weekly or daily bathing in patients with eczema?

Which devices to use in patient teledermoscopy?

Does AI improve FDS in real world application?

LPP guidance from EADV

Hep B guidance for patients on systemics

Highlights:
A new way of thinking about diagnosing mosaic pigmentary disorders

Nail melanoma and melanonychia - length of monitoring and changes to look out for

Cutaneous immune-related adverse events and oncological outcomes

A Delphi consensus on Topical Steroid Withdrawal

European HS guidelines

Frontal Fibrosing Alopecia in men : a systematic review

Validated tools to help with suspected drug allergies and how to approach allergy labelling

Hydrocolloid dressing vs petroleum ointment application post op - how do they compare?

AGA Guidelines
There is a large void when it comes to guidelines for the treatment of androgenetic alopecia, specifically FPHL. In this final lesson, we bring it all together, with recently published 2025 guidelines that help to fill that void and provide worldwide guidance, reflecting common practice in the UK and elsewhere.

Platelet Rich Plasma (PRP)
Some clinicians swear by it, others have had a less favourable experience with it. So, what’s the low-down on PRP for FPHL?